Cite
MLA Citation
A Lightner et al.. “P428 A Phase IB/IIA study of remestemcel-L, an allogeneic bone marrow derived mesenchymal stem cell product, for the treatment of medically refractory Crohn's colitis: A preliminary analysis.” Journal of Crohn's and colitis, vol. 16, n.d., pp. i412–i413. http://access.bl.uk/ark:/81055/vdc_100150514625.0x00001b